Access to diagnostic evaluation and treatment for dementia in Europe

被引:118
作者
Waldemar, Gunhild
Phung, Kieu T. T.
Burns, Alistair
Georges, Jean
Hansen, Finn Ronholt
Iliffe, Steven
Marking, Christine
Rikkert, Marcel Olde
Selmes, Jacques
Stoppe, Gabriela
Sartorius, Norman
机构
[1] Copenhagen Univ Hosp, Rigshosp, Memory Disorder Res Grp, Dept Neurol,Neurosci Ctr, DK-2100 Copenhagen, Denmark
[2] Univ Manchester, Manchester, Lancs, England
[3] Copenhagen Univ Hosp, Dept Med C, Geriatr Sect, Gentofte, Denmark
[4] Royal Free & UCL Med Sch, Ctr Aging Populat Studies, Dept Primary Care & Populat Sci, London, England
[5] Univ Nijmegen, Med Ctr, Dept Geriatr, Alzheimer Ctr Nijmegen, Nijmegen, Netherlands
[6] Univ Basel, Hosp Psychiat, Basel, Switzerland
关键词
dementia; Alzheimer's disease; diagnosis; diagnostic evaluation; diagnostic assessment; early diagnosis; pharmacological treatment; early treatment; QUALITY STANDARDS SUBCOMMITTEE; MANAGING ALZHEIMERS-DISEASE; MILD COGNITIVE IMPAIRMENT; GENERAL-PRACTITIONERS; EARLY RECOGNITION; PRIMARY-CARE; PRACTICE PARAMETER; GUIDELINES; MANAGEMENT; PREVALENCE;
D O I
10.1002/gps.1652
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
This paper reviews and discusses existing barriers to diagnosis and treatment for patients with dementia in Europe as well as approaches to overcome these barriers. The barriers to care are manifold, being present at all levels in each society and between countries in Europe. Multilevel and multifaceted strategies are needed to improve diagnosis and treatments for all patients with cognitive complaints. A multidisciplinary approach based on close collaboration between GPs and specialised memory clinics may be the ideal model for early accurate diagnosis and subsequently early pharmacological and psychosocial interventions. For all healthcare professionals, there should be specialised training in dementia and frequently updated practice guidelines to provide the framework for standards of care. Culture-sensitive strategies to promote public knowledge and destigmatize dementia are essential. Policy makers and authorities should be made aware of the benefits of early access to diagnosis and treatment. Copyright (c) 2006 John Wiley & Sons, Ltd.
引用
收藏
页码:47 / 54
页数:8
相关论文
共 60 条
  • [31] Müller U, 2003, FORTSCHR NEUROL PSYC, V71, P285
  • [32] Italian Neurological Society guidelines for the diagnosis of dementia: revision I
    Musicco, M
    Caltagirone, C
    Sorbi, S
    Bonavita, V
    [J]. NEUROLOGICAL SCIENCES, 2004, 25 (03) : 154 - 167
  • [33] *NAT I CLIN EXC, 2001, GUID US DON RIV CLA
  • [34] Advances in the early detection of Alzheimer's disease
    Nestor, PJ
    Scheltens, P
    Hodges, JR
    [J]. NATURE MEDICINE, 2004, 10 (07) : S34 - S41
  • [35] Dementia in primary care:: why the low detection rate?
    Olafsdóttir, M
    Foldevi, M
    Marcusson, J
    [J]. SCANDINAVIAN JOURNAL OF PRIMARY HEALTH CARE, 2001, 19 (03) : 194 - 198
  • [36] The burden of brain diseases in Europe
    Olesen, J
    Leonardi, M
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2003, 10 (05) : 471 - 477
  • [37] The recognition, assessment and management of dementing disorders: Conclusions from the Canadian Consensus Conference on Dementia
    Patterson, C
    Gauthier, S
    Bergman, H
    Cohen, C
    Feightner, JW
    Feldman, H
    Grek, A
    Hogan, DB
    [J]. CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 2001, 28 : S3 - S16
  • [38] Practice parameter: Early detection of dementia: Mild cognitive impairment (an evidence-based review) - Report of the Quality Standards Subcommittee of the American Academy of Neurology
    Petersen, RC
    Stevens, JC
    Ganguli, M
    Tangalos, EG
    Cummings, JL
    DeKosky, ST
    [J]. NEUROLOGY, 2001, 56 (09) : 1133 - 1142
  • [39] RABINS P, 2002, GUIDELINES TREATMENT, P67
  • [40] Efficacy of donepezil in early-stage Alzheimer disease - A randomized placebo-controlled trial
    Seltzer, B
    Zolnouni, P
    Nunez, M
    Goldman, R
    Kumar, D
    Ieni, J
    Richardson, S
    [J]. ARCHIVES OF NEUROLOGY, 2004, 61 (12) : 1852 - 1856